Loading...

Skip to main content

Call us on + 1 (800) 604-9114 for more information about our products

Looking for specific datasheet Manual/COA/MSDS?
Request a Manual/COA/MSDS

Interested to get a quote about our products?
Request a Quote

eRF3a blocking peptide

eRF3a (D128) Peptide

Gene Names
GSPT1; GST1; ETF3A; eRF3a; 551G9.2
Applications
Blocking
Purity
Synthetic peptide eRF3a (D128). (Note: the amino acid sequence is proprietary).
The purity is >98%.
Synonyms
eRF3a; eRF3a (D128) Peptide; eRF 3a; GSPT 1; GSPT1; GST 1; GST1; GTP binding protein GST1 HS; Transition protein 1; eRF3a blocking peptide
Ordering
For Research Use Only!
Specificity
This peptide can be used with studies using MBS3013598 eRF3a (D128) pAb.
Purity/Purification
Synthetic peptide eRF3a (D128). (Note: the amino acid sequence is proprietary).
The purity is >98%.
Form/Format
1 mg/ml in DI water.
Sequence Length
636
Applicable Applications for eRF3a blocking peptide
Blocking
Preparation and Storage
Store at 4 degree C short term.
Aliquot and store at -20 degree C long term.
Avoid freeze-thaw cycles.
Related Product Information for eRF3a blocking peptide
eRF3a (eukaryotic peptide chain release factor subunit 3a), also known as GSPT1 (G1 to S phase transition 1), is a 499 amino acid protein that belongs to the GTP-binding elongation factor family and is involved in the regulation of cell growth, specifically via control of translation termination. Human eRF3a shares 94% sequence identity with its mouse counterpart, suggesting a conserved function between species. The gene encoding eRF3a maps to human chromosome 16, which encodes over 900 genes and comprises nearly 3% of the human genome. The GAN gene is located on chromosome 16 and, with mutation, may lead to giant axonal neuropathy, a nervous system disorder characterized by increasing malfunction with growth.

NCBI and Uniprot Product Information

NCBI GI #
NCBI GeneID
NCBI Accession #
NCBI GenBank Nucleotide #
UniProt Accession #
NCBI Official Full Name
eukaryotic peptide chain release factor GTP-binding subunit ERF3A isoform 2
NCBI Official Synonym Full Names
G1 to S phase transition 1
NCBI Official Symbol
GSPT1
NCBI Official Synonym Symbols
GST1; ETF3A; eRF3a; 551G9.2
NCBI Protein Information
eukaryotic peptide chain release factor GTP-binding subunit ERF3A
UniProt Protein Name
Eukaryotic peptide chain release factor GTP-binding subunit ERF3A
UniProt Gene Name
GSPT1
UniProt Synonym Gene Names
ERF3A; Eukaryotic peptide chain release factor subunit 3a; eRF3a
UniProt Entry Name
ERF3A_HUMAN

Uniprot Description

GSPT1 iso3: Involved in translation termination in response to the termination codons UAA, UAG and UGA. Stimulates the activity of ERF1. Involved in regulation of mammalian cell growth. Component of the transient SURF complex which recruits UPF1 to stalled ribosomes in the context of nonsense-mediated decay (NMD) of mRNAs containing premature stop codons. Belongs to the GTP-binding elongation factor family. ERF3 subfamily. 2 isoforms of the human protein are produced by alternative splicing.

Protein type: Cell cycle regulation; Hydrolase; RNA-binding; Translation

Chromosomal Location of Human Ortholog: 16p13.1

Cellular Component: intracellular

Molecular Function: GTPase activity; protein binding; GTP binding; translation release factor activity

Biological Process: protein amino acid methylation; mRNA catabolic process, nonsense-mediated decay; translational termination; G1/S transition of mitotic cell cycle

Research Articles on eRF3a

Similar Products

Product Notes

The eRF3a gspt1 (Catalog #AAA3013609) is a Blocking Peptide and is intended for research purposes only. The product is available for immediate purchase. AAA Biotech's eRF3a can be used in a range of immunoassay formats including, but not limited to, Blocking. Researchers should empirically determine the suitability of the eRF3a gspt1 for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process. It is sometimes possible for the material contained within the vial of "eRF3a, Blocking Peptide" to become dispersed throughout the inside of the vial, particularly around the seal of said vial, during shipment and storage. We always suggest centrifuging these vials to consolidate all of the liquid away from the lid and to the bottom of the vial prior to opening. Please be advised that certain products may require dry ice for shipping and that, if this is the case, an additional dry ice fee may also be required.

Precautions

All products in the AAA Biotech catalog are strictly for research-use only, and are absolutely not suitable for use in any sort of medical, therapeutic, prophylactic, in-vivo, or diagnostic capacity. By purchasing a product from AAA Biotech, you are explicitly certifying that said products will be properly tested and used in line with industry standard. AAA Biotech and its authorized distribution partners reserve the right to refuse to fulfill any order if we have any indication that a purchaser may be intending to use a product outside of our accepted criteria.

Disclaimer

Though we do strive to guarantee the information represented in this datasheet, AAA Biotech cannot be held responsible for any oversights or imprecisions. AAA Biotech reserves the right to adjust any aspect of this datasheet at any time and without notice. It is the responsibility of the customer to inform AAA Biotech of any product performance issues observed or experienced within 30 days of receipt of said product. To see additional details on this or any of our other policies, please see our Terms & Conditions page.

Item has been added to Shopping Cart

If you are ready to order, navigate to Shopping Cart and get ready to checkout.

Looking for a specific manual?
Request a Manual

Request more Information

Please complete the form below and a representative will contact you as soon as possible.

Request a Manual

Please complete the form below and a representative will contact you as soon as possible.

Request a Quote

Please complete the form below and a representative will contact you as soon as possible.